A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and β-funaltrexamine on ethanol consumption in the rat

Alcohol

Volumn 15, Issue 4, 1998, Pages 281-289

  Stromberg, Michael F ^a   Casale, Monica ^a   Volpicelli, Laura ^a   Volpicelli, Joseph R ^a   O'Brien, Charles P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Funaltrexamine; Ethanol; Naltrexone; Naltrindole; Opioid antagonists

Indexed keywords

ALCOHOL; BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALTREXONE; NALTRINDOLE; OPIATE ANTAGONIST; OPIATE RECEPTOR;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; APPETITE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; MALE; MOTIVATION; NEUROMODULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ALCOHOL DRINKING; ANIMALS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 0031949311     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-8329(97)00131-6     Document Type: Article

References (38)

1. Beczkowska I. W., Bowen W. D., Bodnar R. J. Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats. Brain Res. 589:1992;291-301.
2. Brown D. R., Holtzman S. G. Suppression of deprivation-induced food and water intake in rats and mice by naloxone. Pharmacol. Biochem. Behav. 11:1979;567-573.
3. Cooper S. J. Effects of opiate agonists and antagonists on fluid intake and saccharin choice in the rat. Neuropharmacology. 22:1983;323-328.
4. Cooper S. J. Behaviourally specific hyperdypsia in the nondeprived rat following acute morphine treatment. Neuropharmacology. 20:1981;469-472.
5. Corbett A. D., Paterson S. J., Kosterlitz H. W. Selectivity of ligands for opioid receptors. Herz A. Hanbook of pharmacology. Opioids I (vol. 104):1993;645-679 Springer-Verlag, New York.
6. Critcher E. C., Lin C. I., Patel J., Myers R. D. Attenuation of alcohol drinking in tetrahydroisoquinoline-treated rats by morphine and naltrexone. Pharmacol. Biochem. Behav. 18:1983;225-229.
7. Drower E. J., Stapelfeld A., Rafferty M. F., DeCosta B. R., Rice K. C., Hammond D. L. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist [D-penicillamine2-D-penicillamine5]enkephalin in the rat. J. Pharmacol. Exp. Ther. 259:1991;725-731.
8. Gilbert P. E., Martin W. R. The effects of morphine- and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 198:1976;66-82.
9. Froehlich J. C., Harts J., Lumeng L., Li T.-K. Naloxone attenuates ethanol intake in rats selectively bred for high alcohol preference. Pharmacol. Biochem. Behav. 35:1990;385-390.
10. Froehlich J. C., Zweifel M., Harts J., Lumeng L., Li T.-K. Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology (Berlin). 103:1991;467-472.
11. Hayes A. G., Skingle M., Tyers M. B. Reversal by beta-funaltrexamine of the antinociceptive effect of opioid agonists in the rat. Br. J. Pharmacol. 88:1986;867-872.
12. Hubbell C. L., Czirr S. A., Hunter G. A., Beaman C. M., LeCann N. C., Reid L. D. Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations. Alcohol. 3:1986;39-54.
13. Hyytia P. Involvement of m-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol. Biochem. Behav. 45:1993;697-701.
14. Jackson H. C., Ripley T. L., Nutt T. J. Exploring δ-receptor function using the selective opioid antagonist naltrindole. Neuropharmacology. 28:1989;1427-1430.
15. Kitchen I., Kennedy A. Effects of δ opioid receptor antagonist naltrindole on opioid induced in vivo release of corticosterone. van Ree J. M., Muldewr A. H., Wiegant V. M., van Wiersma Griedanus T. B. New leads in opioid research. 1990;2321-2322 Excerpta Medica, Amsterdam.
16. Krishnan-Sarin S., Portoghese P. S., Li T.-K., Froehlich J. C. The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol. Biochem. Behav. 52:1995;153-159.
17. Krishnan-Sarin S., Jing S. L., Kurtz D. L., Zweifel M., Portoghese P. S., Li T.-K., Froehlich J. C. The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology (Berlin). 120:1995;177-185.
18. Le A. D., Poulos C. X., Quan B., Chow S. The effects of blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res. 630:1993;330-332.
19. Lynch W. C. Opiate blockade inhibits saccharin intake and blocks normal preference acquisition. Pharmacol. Biochem. Behav. 24:1986;833-836.
20. McBride W. J., Murphy J. M., Lumeng L., Li T.-K. Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats. Alcohol. 7:1990;199-205.
21. 3H] naltrexone in the central nervous system of the rat. Drug Metab. Dispos. 4:1976;276-280.
22. Myers R. D., Critcher E. C. Naloxone alters alcohol drinking induced in the rat by tetrahydopapaveroline (THP) infused ICV. Pharmacol. Biochem. Behav. 16:1982;827-836.
23. Myers R. D., Borg S., Mossberg R. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol. 3:1986;383-388.
24. Myers R. D., Lankford M. F. Suppression of alcohol preference in high alcohol drinking rats. Efficacy of amperozide vs. naltrexone Neuropsychopharmacology. 14:1996;139-149.
25. Negus S. S., Henrikson S. J., Mattox A., Pasternak G. W., Portoghese P. S., Takemori A. E., Wenger M. B., Koob G. F. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J. Pharmacol. Exp. Ther. 265:1993;1245-1252.
26. O'Malley S. S., Jaffe A. J., Chang G., Schottenfeld R. S., Meyer R. E., Rounsavill B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study Arch. Gen. Psychiatry. 49:1992;881-887.
27. Reid L. D., Delconte J. D., Nichols M. L., Bilsky E. J., Hubbell C. L. Test of the opioid deficiency hypothesis of alcoholism. Alcohol. 8:1991;247-257.
28. Rogers H., Hayes A. G., Birch P. J., Traynor J. R., Lawrence A. J. The selectivity of the opioid antagonist, naltrindole, for delta receptors. J. Pharm. Pharmacol. 42:1990;358-359.
29. Rothman R. B., Long J. B., Bykov V., Jacobson A. E., Rice K. C., Holaday J. W. B-FNA binds irreversibly to the opiate receptor complex. In vivo and in vitro evidence J. Pharmacol. Exp. Ther. 247:1988;405-416.
30. Schwarz-Stevens K. S., Files F. J., Samson H. H. Effects of morphine and naloxone on ethanol- and sucrose-reinforced responding in nondeprived rats. Alcohol. Clin. Exp. Res. 16:1992;822-832.
31. Spanagel R. The influence of opioid antagonists on the discriminative stimulus effects of ethanol. Pharmacol. Biochem. Behav. 54:1996;645-649.
32. Stromberg M. F., Meister S., Volpicelli J. R., Ulm R. R. Morphine enhances selection of both sucrose and ethanol in a two-bottle test. Alcohol. 14:1997;55-62.
33. Takemori A. E., Portoghese P. S. Comparative antagonism by naltrexone and naloxone of μ, κ and δ agonists. Eur. J. Pharmacol. 154:1984;101-104.
34. Takemori A. E., Larson D. L., Portoghese P. S. The irreversible narcotic antagonist and reversible agonist properties of the fumarate methyl ester derivative of naltrexone. Eur. J. Pharmacol. 70:1981;445-451.
35. Touzani K., Akarid K., Velley L. Modulation of saccharin preference by morphine and naloxone. Inversion of drug effects as a function of saccharin concentration Pharmacol. Biochem. Behav. 38:1991;37-41.
36. Volpicelli J. R., Alterman A. I., Hayashida M., O'Brien C. P. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry. 49:1992;876-880.
37. Volpicelli J. R., Davis M. A., Olgin J. E. Naltrexone blocks the postshock increase of ethanol consumption. Life Sci. 38:1986;841-847.
38. Ward S. J., Portoghese P. S., Takemori A. E. Pharmacological characterization in vivo of novel opioid, beta-funaltrexamine. J. Pharmacol. Exp. Ther. 220:1982;494-498.